NEW YORK (GenomeWeb) – Swedish biotech company Genovis announced today that it has settled a patent infringement lawsuit filed against Promega related to its antibody characterization technology, ending all litigation between the companies.

The specific details of the settlement were not disclosed, but Genovis said that Promega has taken a royalty-bearing, worldwide license to the intellectual property involved in the litigation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.